IfuduO., MayersJ.D., CohenL.S.. Correlates of vascular access and nonvascular access-related hospitalizations in hemodialysis patients.Am J Nephrol1996; 16: 118–23.
2.
BresciaM.J., CiminoJ.E., AppellK., HurwichB.J., ScribnerB.H.Chronic hemodialysis using venipuncture and a surgically created arteriovenous fistula. 1966 (classical article).J Am Soc Nephrol1999; 10: 193–9.
3.
Van BiesenW., VanholderR., LameireN.The role of peritoneal dialysis as the first-line renal replacement modality (editorial).Perit Dial Int2000; 20: 75–383.
4.
LameireN., Van BiesenW.The pattern of referral of patients with end-stage renal disease to the nephrologist a European survey.Nephrol Dial Transplant1999; 14(Suppl 6): S16–23.
5.
RodriguezJ.A., ArmadansL., FerrerE.. The function of permanent vascular access.Nephrol Dial Transplant2000; 15: 402–8.
6.
Stehman-BreenC.O., SherrardD.J., GillenD., CapsM.Determinants of type and timing of initial permanent hemodialysis vascular access.Kidney Int2000; 57: 639–45.
7.
WoodsJ.D., TurenneM.N., StrawdermanR.L.. Vascular access survival among incident hemodialysis patients in the United States.Am J Kidney Dis1997; 30: 50–7.
8.
KapoianT., ShermanR.A.A brief history of vascular access for hemodialysis: an unfinished story.Semin Nephrol1997; 17: 239–45.
9.
De MeesterJ., VanholderR., De RooseJ., RingoirS.Factors and complications affecting catheter and technique survival with permanent single-lumen dialysis catheters.Nephrol Dial Transplant1994; 9: 678–83.
10.
BogaertA.M., VanholderR., De RooseJ.. Pseudo-Kaposi's sarcoma as a complication of Cimino-Brescia arteriovenous fistulas in hemodialysis patients.Nephron1987; 46: 170–3.
11.
Braun-DullaeusR.C., MannM.J., DzauV.J.Cell cycle progression: new therapeutic target for vascular proliferative disease.Circulation1998; 98: 82–9.
12.
FanP.Y., SchwabS.J.Vascular access: concepts for the 1990s (editorial).J Am Soc Nephrol1992; 3: 1–11.
13.
MayR.E., HimmelfarbJ., YenicesuM.. Predictive measures of vascular access thrombosis: a prospective study.Kidney Int1997; 52: 1656–62.
14.
De MarchiS., FalletiE., GiacomelloR.. Risk factors for vascular disease and arteriovenous fistula dysfunction in hemodialysis patients.J Am Soc Nephrol1996; 7: 1169–77.
15.
HernandezE., PragaM., AlamoC.. Lipoprotein(a) and vascular access survival in patients on chronic hemodialysis.Nephron1996; 72: 145–9.
16.
SheminD., LapaneK.L., BaussermanL.. Plasma total homocysteine and hemodialysis access thrombosis: a prospective study.J Am Soc Nephrol1999; 10: 1095–9.
17.
SirrsS., DuncanL., DjurdjevO.. Homocyst(e)ine and vascular access complications in haemodialysis patients: insights into a complex metabolic relationship.Nephrol Dial Transplant1999; 14: 738–43.
18.
MannsB.J., BurgessE.D., ParsonsH.G.. Hyperhomocysteinemia, anticardiolipin antibody status, and risk for vascular access thrombosis in hemodialysis patients.Kidney Int1999; 55: 315–20.
NeyraN.R., IkizlerT.A., MayR.E.. Change in access blood flow over time predicts vascular access thrombosis.Kidney Int1998; 54: 1714–9.
24.
KrivitskiN.M.Theory and validation of access flow measurement by dilution technique during hemodialysis.Kidney Int1995; 48: 244–50.
25.
GadallahM.F., PaulsonW.D., VickersB., WorkJ.Accuracy of Doppler ultrasound in diagnosing anatomic stenosis of hemodialysis arteriovenous access as compared with fistulography.Am J Kidney Dis1998; 32: 273–7.
HarterH.R., BurchJ.W., MajerusP.W.. Prevention of thrombosis in patients on hemodialysis by low-dose aspirin.N Engl J Med1979; 301: 577–9.
30.
AndrassyK., MallucheH., BornefeldH.. Prevention of p.o. clotting of av. cimino fistulae with acetylsalicyl acid. Results of a prospective double-blind study.Klin Wochenschr1974; 52: 348–9.
31.
BeathardG.A.Thrombolysis versus surgery for the treatment of thrombosed dialysis access grafts.J Am Soc Nephrol1995; 6: 1619–24.
32.
AyusJ.C., Sheikh-HamadD.Silent infection in clotted hemodialysis access grafts.J Am Soc Nephrol1998; 9: 1314–7.
